clinical trial · NCT01106716
Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Postherpetic Neuralgia
Postherpetic NeuralgiaPlaceboKAI-1678Lidocaine
brief summary
The purpose of this study is to determine whether KAI-1678 is effective in the treatment of postherpetic neuralgia pain
started
Mar 1, 2009
primary completion
Mar 1, 2010
completion
Apr 1, 2010
last updated
Sep 2, 2025
official title
A Double-Blind, Randomized, Placebo- and Active-Comparator-Controlled, Single-Dose Study to Assess the Efficacy of KAI-1678 Administered by Subcutaneous Infusion in Subjects With Postherpetic Neuralgia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol